Loading…
TuHURA Biosciences, Inc. is projected to rise to $2.84 by 2027, a +19% move from its current price of $2.39. HURA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $2.28 | $2.39 | $2.51 | -0.05% |
| Jul 13 | $2.23 | $2.39 | $2.56 | -0.11% |
| Jul 14 | $2.19 | $2.39 | $2.60 | -0.16% |
| Jul 15 | $2.16 | $2.38 | $2.63 | -0.21% |
| Jul 16 | $2.14 | $2.38 | $2.66 | -0.27% |
| Jul 17 | $2.11 | $2.38 | $2.68 | -0.32% |
| Jul 18 | $2.09 | $2.38 | $2.71 | -0.37% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.09 | $2.38 | $2.71 | -0.37% |
| Week 2 | $1.98 | $2.37 | $2.85 | -0.74% |
| Week 3 | $1.89 | $2.36 | $2.95 | -1.11% |
| Week 4 | $1.82 | $2.35 | $3.05 | -1.48% |
| Week 5 | $1.76 | $2.35 | $3.13 | -1.84% |
| Week 6 | $1.71 | $2.34 | $3.20 | -2.21% |
| Week 7 | $1.66 | $2.33 | $3.27 | -2.57% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
TuHURA Biosciences, Inc. is a clinical stage immuno-oncology company that develops novel technologies for cancer immunotherapies. Its lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.
The company is preparing to initiate a Phase 3 registration trial of IFx-2.0 as an adjunctive therapy to Keytruda, and Delta receptor technology to develop tumor microenvironment modulators in the form of first-in-class bi-functional and bi-specific antibody-drug conjugates targeting Myeloid Derived Suppressor Cells. The company was formerly known as Morphogenesis, Inc. and changed its name to TuHURA Biosciences, Inc.
in December 2023. It was founded in 1995 and is based in Tampa, Florida. TuHURA Biosciences, Inc. operates as a subsidiary of CohBar, Inc.
TuHURA Biosciences, Inc. (HURA) is trading at $2.24, with a market capitalization of $142.65M and a market rank of 4039. The asset’s price outlook is shown by a multi-year forecast, with the average price rising from $2.24 in 2026 to $15.07 in 2050 and a maximum forecast of $34.65 by 2050.
The forecast also shows a bullish path in later years, with sentiment turning bullish from 2028 onward and an overall long-term upside.
A major floor 41.0% below — a decisive break under it would weaken the trend.
The nearest floor, 17.8% below — buyers have tended to step in here.
The nearest ceiling, 13.4% above — a clean break opens room to run.
A major ceiling 31.8% above — clearing it would confirm fresh momentum.
Key HURA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HURA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.32 | Buy | $2.35 | Buy |
| MA 10 | $2.33 | Buy | $2.35 | Buy |
| MA 20 | $2.38 | Buy | $2.35 | Buy |
| MA 50 | $2.33 | Buy | $2.29 | Buy |
| MA 100 | $2.13 | Buy | $2.15 | Buy |
| MA 200 | $1.87 | Buy | $2.40 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.83 | Neutral |
| Stoch RSI (14) | 35.67 | Neutral |
| CCI (20) | 6.46 | Neutral |
| Williams %R (14) | -58.18 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -9.47 | Sell |
| Bollinger %B (20,2) | 0.52 | Neutral |
| Stochastic %K (14) | 41.82 | Neutral |
| TRIX (15) | 0.12 | Buy |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 51.64 | Neutral |
| Momentum (10) | -0.20 | Sell |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 2.30 | Buy |
| ADX (14) | 8.41 | Neutral |
| ATR (14) | 0.10 | Info |
The near-term technical picture is NEUTRAL, with RSI(14) at 50. The 50-day simple moving average is $2.33 and the 200-day simple moving average is $1.87. The price sits above the 200-day MA with support at $1.97 and resistance at $2.71. The thirty-day range spans from $1.58 to $3.17, indicating a wide intramonth trading band and subdued momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.44 | $2.39 | $3.05 | 0% | Neutral | |
| $2.10 | $2.84 | $4.15 | +19% | Neutral | |
| $2.68 | $3.83 | $5.94 | +60% | Bullish | |
| $2.96 | $4.43 | $7.18 | +85% | Bullish | |
| $3.04 | $4.74 | $7.99 | +98% | Bullish | |
| $2.95 | $4.78 | $8.32 | +100% | Bullish | |
| $2.98 | $5.02 | $9.00 | +110% | Bullish | |
| $2.77 | $4.83 | $8.87 | +102% | Bullish | |
| $3.22 | $5.81 | $10.94 | +143% | Bullish | |
| $4.52 | $8.42 | $16.20 | +252% | Bullish | |
| $4.34 | $9.48 | $19.93 | +297% | Bullish | |
| $8.91 | $19.81 | $45.56 | +729% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.44 | $2.39 | $2.95 | +0.00% |
| August 2026 | $2.04 | $2.45 | $3.08 | +2.72% |
| September 2026 | $1.86 | $2.28 | $2.91 | -7.25% |
| October 2026 | $1.73 | $2.14 | $2.78 | -6.04% |
| November 2026 | $1.80 | $2.24 | $2.95 | +4.80% |
| December 2026 | $1.82 | $2.29 | $3.05 | +2.30% |
Click any year to see its month-by-month HURA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The HURA price prediction for 2026 points to an average of $2.39 (low $0.44, high $3.05) — a potential gain of 0% on today's $2.39. A consolidation phase looks the most probable path here.
In 2027, HURA is projected to trade between $2.10 and $4.15, averaging $2.84 — a potential gain of +19% from today's $2.39. That is up +19% on the projected 2026 average. Price action looks broadly range-bound.
TuHURA Biosciences, Inc.'s 2028 outlook centres on $3.83, within a $2.68 to $5.94 range. That is up +35% on the projected 2027 average. That marks a +60% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, HURA could reach as high as $7.18, with a base case around $4.43 and support toward $2.96 — roughly +85% from $2.39. Momentum favours further upside here.
Expect HURA to range from $3.04 to $7.99 through 2030. The $4.74 average target implies a +98% move from current prices. That is up +7% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The HURA price prediction for 2031 points to an average of $4.78 (low $2.95, high $8.32) — a potential gain of +100% on today's $2.39. Momentum favours further upside here.
In 2032, HURA is projected to trade between $2.98 and $9.00, averaging $5.02 — a potential gain of +110% from today's $2.39. That is up +5% on the projected 2031 average. Buyers look set to stay in control over this stretch.
TuHURA Biosciences, Inc.'s 2033 outlook centres on $4.83, within a $2.77 to $8.87 range. That is -4% versus the projected 2032 average. That marks a +102% change versus current levels. Momentum favours further upside here.
By 2034, HURA could reach as high as $10.94, with a base case around $5.81 and support toward $3.22 — roughly +143% from $2.39. Buyers look set to stay in control over this stretch.
Expect HURA to range from $4.52 to $16.20 through 2035. The $8.42 average target implies a +252% move from current prices. That is up +45% on the projected 2034 average. Momentum favours further upside here.
The HURA price prediction for 2040 points to an average of $9.48 (low $4.34, high $19.93) — a potential gain of +297% on today's $2.39. Buyers look set to stay in control over this stretch.
In 2050, HURA is projected to trade between $8.91 and $45.56, averaging $19.81 — a potential gain of +729% from today's $2.39. That is up +109% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in HURA today (≈ 418.410042 HURA) could be worth
$8,288.88
+$7,288.88 (+729%) by 2050 · US Dollar
Based on the average projected HURA price of $19.81 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HURAwould be worth at today's price.
$1,000 invested in HURA on Jul 10, 2025 (≈ 396.8254 HURA) would be worth
$948.41
-$51.59 (-5.2%) today · 0.95× · US Dollar
Based on a HURA entry price of $2.52 vs. today's $2.39.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.44 | $979.51 | -2.0% |
| 1 month ago | $2.08 | $1,149.04 | +14.9% |
| 3 months ago | $2.27 | $1,052.86 | +5.3% |
| 6 months ago | $0.715 | $3,342.66 | +234.3% |
| 1 year ago | $2.52 | $948.41 | -5.2% |
| All time (5.0y) ago | $3,132.5 | $0.76 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HURA forecast.
Our base-case forecast reaches $4.80 around 2032.
Implied market cap at $4.80: $305.68M
The multi-year forecast shows a bullish path with 2026–2027 Neutral then rising in later years. The 2030 average price is $4.13 with an 84.2% ROI, the 2040 average price is $7.26 with a 224% ROI, and the 2050 average price is $15.07 with a 572.6% ROI. The maximum forecast by year reaches $7.12 in 2030 and $34.65 in 2050, underscoring substantial upside potential over the long term.
These figures are estimates, not guarantees, and reflect possible outcomes given market dynamics and company developments.
Tap a question to reveal the answer.
2030 avg $4.13; min $2.57; max $7.12; ROI 84.2%; sentiment BULLISH.
Forecasts show rising averages over time with 2027 avg $2.51 (ROI 12.1%) and 2050 avg $15.07 (ROI 572.6%), but 2026 shows Neutral sentiment and ROI 0%. These are estimates, not guarantees.
Yes, the max forecast reaches $34.65 by 2050 (with earlier highs such as $15.81 in 2040 and $13.53 in 2035), so a $10 target lies within the forecast path. These are not guarantees.
Current price is $2.24 and market cap is $142.65M.
RSI(14) is 50, SMA50 is $2.33, SMA200 is $1.87, support $1.97, resistance $2.71, and the 30-day range is $1.58 to $3.17.
TuHURA Biosciences, Inc. Community Discussion
0Share your TuHURA Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.